NYSE:CVS - CVS Health Stock Price, Price Target & More

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Tuesday, March 13th. Investors of record on Monday, April 23rd will be paid a dividend of $0.50 per share on Thursday, May 3rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.79%. The ex-dividend date of this dividend is Friday, April 20th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its earnings results on Wednesday, May, 2nd. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.09. The pharmacy operator had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.77 billion. CVS Health had a net margin of 3.59% and a return on equity of 17.45%. The business's quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.17 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $6.87-7.08 for the period, compared to the Thomson Reuters consensus estimate of $6.45. CVS Health also updated its Q2 guidance to $1.59-1.64 EPS.

19 Wall Street analysts have issued 1 year price targets for CVS Health's stock. Their forecasts range from $68.00 to $99.00. On average, they anticipate CVS Health's stock price to reach $86.8750 in the next twelve months. View Analyst Ratings for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Media stories about CVS stock have been trending somewhat positive recently, according to Accern. The research firm rates the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CVS Health earned a daily sentiment score of 0.18 on Accern's scale. They also assigned news articles about the pharmacy operator an impact score of 47.89 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

CVS Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.89%), Barrow Hanley Mewhinney & Strauss LLC (1.78%), Northern Trust Corp (1.52%), Franklin Resources Inc. (1.20%), Veritas Asset Management LLP (1.12%) and Dimensional Fund Advisors LP (1.06%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Prudential Financial Inc., Element Capital Management LLC, The Manufacturers Life Insurance Company , Boston Partners, Lord Abbett & CO. LLC, Crawford Investment Counsel Inc. and Equity Investment Corp. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Schwab Charles Investment Management Inc., Carmignac Gestion, Barrow Hanley Mewhinney & Strauss LLC, Rockefeller Capital Management L.P., Millennium Management LLC, Russell Investments Group Ltd. and Toronto Dominion Bank. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $71.60.

CVS Health has a market capitalization of $68.87 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]